We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





World's First Large Sample Volume, Open-Assay, Super-fast, Ultra-Sensitive, and Sample-To-Answer PCR Instrument

By LabMedica International staff writers
Posted on 26 Jul 2023

OnsiteGene Inc. More...

(San Diego, CA, USA) is presenting the world's first large sample volume, open-assay, super-fast, ultra-sensitive, and sample-to-answer PCR instrument at AACC 2023.

The groundbreaking PeakV from OnsiteGene is a sample-to-answer instrument that represents a paradigm shift in PCR testing. By utilizing rapid thermal cycling and real-time fluorescent imaging to perform 40 cycles within a span of just 5 minutes, it delivers an unmatched performance. The device can carry out low copy multiplex qPCR in merely seven minutes and RT-qPCR in nine minutes. Equipped with a substantial sample volume capacity of up to 5mL, PeakV also features automated nested PCR and magnetic beads-based nucleic acid extraction, thereby enhancing its sensitivity and specificity, outperforming conventional qPCR techniques.

PeakV's user-programmable interface and affordable, contamination-resistant open-assay cartridge offer a versatile platform for third-party assay developers to design customized sample-to-answer PCR tests. This provides researchers and clinicians with the capacity to explore a myriad of possibilities within molecular diagnostics. The PeakV cartridge eschews a microfluidics-based design, which means it lacks microchannels, microvalves, and microchambers. This allows the cartridge to accommodate large quantities of reagents and samples in its spacious chambers, without the constraints typically associated with microchannels and microchambers during fluid transfer and mixing. Thanks to these features, the PeakV cartridge delivers a high-quality technical performance that is on par with a manual laboratory test operation.

Related Links:
OnsiteGene Inc.


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Specimen Radiography System
TrueView 200 Pro
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: Prof. Nicholas Schwab has found a biomarker that can predict treatment outcome of glatirameracetate in MS patients (Photo courtesy of Uni MS - M. Ibrahim)

Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients

Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.